Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2020-03-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Expectations and Body Image in Breast Reconstruction
NCT04714463
Breast Reconstruction
NCT06332937
Autologous vs. Implant-based Breast Reconstruction
NCT06195865
Complications and Long-term Satisfaction in Autologous vs. Implant-Based Breast Reconstruction
NCT06295042
Patient Preferences for Breast Reconstruction After Mastectomy
NCT01488357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interviewed -implant loss
Patients who have had immediate breast reconstruction and lost the implant due to for example infection.
No interventions assigned to this group
Questionnaires - implant loss
Patients who have had immediate breast reconstruction and lost the implant due to for example infection.
No interventions assigned to this group
Questionnaires - controls
Patients who have had immediate breast reconstruction without complications
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>18 years
* Have lost an implant after a mastectomy and immediate breast reconstruction
Exclusion Criteria
* inability to speak and understand Swedish
* relapse of breast cancer after the reconstruction
* metastatic disease
* psychiatric co-morbidity.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vastra Gotaland Region
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emma Hansson, PhD
Role: PRINCIPAL_INVESTIGATOR
Göteborg University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Västra Götaland
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Weick L, Ericson A, Sandman L, Bostrom P, Hansson E. Patient experience of implant loss after immediate breast reconstruction: An interpretative phenomenological analysis. Health Care Women Int. 2023 Jan;44(1):61-79. doi: 10.1080/07399332.2021.1944152. Epub 2021 Aug 24.
Weick L, Lunde C, Hansson E. The effect of implant loss after immediate breast reconstruction on patient satisfaction with outcome and quality of life after five years - a case-control study. J Plast Surg Hand Surg. 2023 Feb-Dec;57(1-6):263-270. doi: 10.1080/2000656X.2022.2061501. Epub 2022 Apr 15.
Related Links
Access external resources that provide additional context or updates about the study.
Full text article
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-06214
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.